Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study
View ORCID ProfileAdam Penn-Nicholson, Sophia B. Georghiou, Nelly Ciobanu, Mubin Kazi, Manpreet Bhalla, Anura David, Francesca Conradie, Morten Ruhwald, Valeriu Crudu, Camilla Rodrigues, Vithal Prasad Myneedu, Lesley Scott, Claudia M Denkinger, Samuel G Schumacher, Xpert XDR Trial Consortium
doi: https://doi.org/10.1101/2021.05.06.21256505
Adam Penn-Nicholson
1Foundation for Innovative New Diagnostics, Campus Biotech, 9 Chemin des Mines 1202 Geneva, Switzerland
PhDSophia B. Georghiou
1Foundation for Innovative New Diagnostics, Campus Biotech, 9 Chemin des Mines 1202 Geneva, Switzerland
PhDNelly Ciobanu
2Institute of Phthisiopneumology “Chiril Draganiuc”, 13, C. Virnav street MD 2025, Chisinau, the Republic of Moldova
MDMubin Kazi
3P.D. Hinduja Hospital and Medical Research Centre, SVS Rd, Mahim West, Shivaji Park Mumbai, Maharashtra 400016, India
PhDManpreet Bhalla
4National Institute of TB and Respiratory Diseases, Sri Aurobindo Marg Near Qutub Minar, Mehrauli, New Delhi, Delhi 110030, India
MDAnura David
5University of the Witwatersrand, School of Pathology, York Road, Parktown, Johannesburg, 2193, South Africa
MScFrancesca Conradie
5University of the Witwatersrand, School of Pathology, York Road, Parktown, Johannesburg, 2193, South Africa
MBBChMorten Ruhwald
1Foundation for Innovative New Diagnostics, Campus Biotech, 9 Chemin des Mines 1202 Geneva, Switzerland
MDValeriu Crudu
2Institute of Phthisiopneumology “Chiril Draganiuc”, 13, C. Virnav street MD 2025, Chisinau, the Republic of Moldova
MDCamilla Rodrigues
3P.D. Hinduja Hospital and Medical Research Centre, SVS Rd, Mahim West, Shivaji Park Mumbai, Maharashtra 400016, India
MDVithal Prasad Myneedu
4National Institute of TB and Respiratory Diseases, Sri Aurobindo Marg Near Qutub Minar, Mehrauli, New Delhi, Delhi 110030, India
MDLesley Scott
5University of the Witwatersrand, School of Pathology, York Road, Parktown, Johannesburg, 2193, South Africa
PhDClaudia M Denkinger
1Foundation for Innovative New Diagnostics, Campus Biotech, 9 Chemin des Mines 1202 Geneva, Switzerland
6Heidelberg University Hospital, Center of Infectious Diseases, Im Neuenheimer Feld 324, 69120 and German Center of Infection Research, Site Heidelberg, Heidelberg, Germany
MDSamuel G Schumacher
1Foundation for Innovative New Diagnostics, Campus Biotech, 9 Chemin des Mines 1202 Geneva, Switzerland
PhDData Availability
Individual, de-identified participant data will be shared, including data dictionaries. Other documents that have been made available include the study protocol and statistical analysis plan. Templates of the informed consent forms may be shared upon request. The data will be available immediately following publication with no end date. The data will be shared with anyone who wishes to access the data. The data will be available for any purpose of analyses. For data, please contact the corresponding author.
Posted May 07, 2021.
Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study
Adam Penn-Nicholson, Sophia B. Georghiou, Nelly Ciobanu, Mubin Kazi, Manpreet Bhalla, Anura David, Francesca Conradie, Morten Ruhwald, Valeriu Crudu, Camilla Rodrigues, Vithal Prasad Myneedu, Lesley Scott, Claudia M Denkinger, Samuel G Schumacher, Xpert XDR Trial Consortium
medRxiv 2021.05.06.21256505; doi: https://doi.org/10.1101/2021.05.06.21256505
Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study
Adam Penn-Nicholson, Sophia B. Georghiou, Nelly Ciobanu, Mubin Kazi, Manpreet Bhalla, Anura David, Francesca Conradie, Morten Ruhwald, Valeriu Crudu, Camilla Rodrigues, Vithal Prasad Myneedu, Lesley Scott, Claudia M Denkinger, Samuel G Schumacher, Xpert XDR Trial Consortium
medRxiv 2021.05.06.21256505; doi: https://doi.org/10.1101/2021.05.06.21256505
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2697)
- Dermatology (231)
- Emergency Medicine (406)
- Epidemiology (12336)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4181)
- Geriatric Medicine (393)
- Health Economics (690)
- Health Informatics (2704)
- Health Policy (1011)
- Hematology (366)
- HIV/AIDS (865)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3962)
- Nursing (216)
- Nutrition (587)
- Oncology (2090)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1136)
- Primary Care Research (464)
- Public and Global Health (6596)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)